Clinical Trials Directory

Trials / Completed

CompletedNCT05209139

Beetroot Juice Ingestion Effects on Field Hockey Performance.

Acute Effects of Beetroot Juice Ingestion on Neuromuscular Performance and Match-play Demands in Elite Female Hockey Players.

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
11 (actual)
Sponsor
Universidad Francisco de Vitoria · Academic / Other
Sex
Female
Age
18 Years – 35 Years
Healthy volunteers
Accepted

Summary

Scientific evidence supports that only a few dietary supplements have reported good evidence for improving sports performance, between we can mention beetroot juice supplementation with doses \> 5 mmol of NO3-. In this randomized placebo-controlled study, we investigated the effects of BJ acute supplementation in improving neuromuscular performance and match-play demands in female field hockey players.

Detailed description

Beetroot juice supplementation has demonstrated good evidence for improving sports performance, however, benefits in team sports, especially in female athletes, are underrepresented. In this randomized placebo-controlled study, we investigated the effects of beetroot juice acute supplementation in improving neuromuscular performance and match-play demands.Testing sessions will comprise a neuromuscular test battery consisting of a countermovement jump (CMJ), isometric handgrip strength, 20-m sprint and repeated sprint ability test, followed by a 20-minute simulated field hockey Physical match activity (distances, speeds, accelerations and decelerations) will be monitored in real-time using an inertial tracking system

Conditions

Interventions

TypeNameDescription
DIETARY_SUPPLEMENTBeetroot juiceOne serving 70 mL of beetroot juice (6.4 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session.
DIETARY_SUPPLEMENTBeetroot juice placeboOne serving 70 mL of beetroot juice placebo (0.04 mmol of NO3-; Beet-It-Pro Elite Shot, James White Drinks Ltd., Ipswich, UK) 3 h before initiating the testing session.

Timeline

Start date
2018-03-01
Primary completion
2018-03-08
Completion
2018-03-15
First posted
2022-01-26
Last updated
2022-04-14

Locations

1 site across 1 country: Spain

Source: ClinicalTrials.gov record NCT05209139. Inclusion in this directory is not an endorsement.